Old and new biomarkers of heart failure

Area of Science:

• Cardiology
• Biomarker Discovery
• Clinical Diagnostics

Background:

• Heart failure (HF) is a complex syndrome with a poor prognosis, stemming from cardiac dysfunction and neurohormonal imbalance.
• Current diagnostic methods for HF lack a single definitive test, often relying on clinical assessment, which can be inadequate.
• Accurate diagnosis and risk stratification are crucial for effective HF management, driving the need for reliable biomarkers.

Purpose of the Study:

• To outline the characteristics of an ideal heart failure biomarker.
• To assess the analytical performance and clinical utility of existing HF biomarker assays.
• To evaluate emerging biomarkers and propose a framework for optimizing the search for new diagnostic and prognostic markers.

Main Methods:

• Review of existing literature on heart failure biomarkers.
• Analysis of analytical performance and clinical relevance of current biomarker assays.
• Evaluation of novel biomarkers and proposed strategies for biomarker discovery.

Main Results:

• Discussion on the attributes of an ideal HF biomarker, emphasizing sensitivity, specificity, and accessibility.
• Overview of the analytical and clinical performance of established biomarkers like natriuretic peptides.
• Exploration of newer biomarkers with potential for improved diagnostic and prognostic accuracy in HF.

Conclusions:

• The development of ideal heart failure biomarkers is essential for accurate diagnosis and risk stratification.
• Current biomarkers have limitations, necessitating ongoing research into novel markers.
• A structured approach to biomarker discovery is proposed to enhance the identification of efficient diagnostic and prognostic tools for HF.